CDC recommends common antibiotic as a 'Morning-After' STI prevention
The U.S. Centers for Disease Control and Prevention (CDC) is preparing to suggest the use of a potent antibiotic for preventing sexually transmitted infections (STIs). The CDC recently released preliminary guidelines, advising healthcare professionals to consider prescribing doxycycline as a preventive measure against the spread of these infections.
This approach, known as Doxy-PEP (short for doxycycline post-exposure), suggests taking the antibiotic following a potential exposure to an STI rather than waiting until a disease is diagnosed. If these initial recommendations are accepted, Doxy-PEP would be recommended for individuals other than gay and bisexual men, including men who have sexual relations with men and transgender women, provided they have previously been diagnosed with at least one STI caused by bacteria within the past year. These infections include gonorrhea, chlamydia, or syphilis.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.